JP2021535209A5 - - Google Patents
Info
- Publication number
- JP2021535209A5 JP2021535209A5 JP2021534405A JP2021534405A JP2021535209A5 JP 2021535209 A5 JP2021535209 A5 JP 2021535209A5 JP 2021534405 A JP2021534405 A JP 2021534405A JP 2021534405 A JP2021534405 A JP 2021534405A JP 2021535209 A5 JP2021535209 A5 JP 2021535209A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- peptide compound
- seq
- use according
- cancer cells
- Prior art date
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862722726P | 2018-08-24 | 2018-08-24 | |
| US62/722,726 | 2018-08-24 | ||
| US201962804063P | 2019-02-11 | 2019-02-11 | |
| US62/804,063 | 2019-02-11 | ||
| PCT/CA2019/051170 WO2020037434A1 (en) | 2018-08-24 | 2019-08-26 | Methods and compounds for targeting sortilin receptors and inhibiting vasculogenic mimicry |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021535209A JP2021535209A (ja) | 2021-12-16 |
| JP2021535209A5 true JP2021535209A5 (https=) | 2022-08-29 |
| JPWO2020037434A5 JPWO2020037434A5 (https=) | 2022-08-29 |
| JP7592320B2 JP7592320B2 (ja) | 2024-12-02 |
Family
ID=69591094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534405A Active JP7592320B2 (ja) | 2018-08-24 | 2019-08-26 | ソルチリン受容体を標的化し血管擬態を阻害するための方法及び化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220000971A1 (https=) |
| EP (1) | EP3844190A4 (https=) |
| JP (1) | JP7592320B2 (https=) |
| CN (1) | CN113286820B (https=) |
| AU (1) | AU2019324747A1 (https=) |
| CA (1) | CA3110414A1 (https=) |
| IL (1) | IL281043A (https=) |
| WO (1) | WO2020037434A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107708733B (zh) | 2015-04-07 | 2022-11-15 | 艾利妥 | 抗分拣蛋白抗体和其使用方法 |
| CA3006313C (en) | 2015-11-24 | 2020-02-11 | Transfert Plus, S.E.C. | Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy |
| AU2018316166A1 (en) | 2017-08-07 | 2020-02-06 | The Regents Of The University Of California | Platform for generating safe cell therapeutics |
| TWI809147B (zh) | 2018-07-13 | 2023-07-21 | 美商阿列克特有限責任公司 | 抗分揀蛋白抗體及其使用方法 |
| CN116731113A (zh) * | 2022-03-01 | 2023-09-12 | 上海智肽生物科技有限公司 | 针对sort1的多肽化合物及其药物偶联物 |
| CN119403786A (zh) | 2022-06-23 | 2025-02-07 | 德罗普尼尔生物有限公司 | 选择性诱导细胞外靶标在溶酶体中降解的双功能分子 |
| CN120641133A (zh) * | 2022-11-14 | 2025-09-12 | 瑟瑞技术公司 | 用于刺激抗肿瘤免疫应答的药物缀合物化合物 |
| WO2025054707A1 (en) * | 2023-09-11 | 2025-03-20 | Theratechnologies Inc. | Peptide conjugates of camptothecin analogs and uses thereof |
| WO2025208212A1 (en) * | 2024-04-02 | 2025-10-09 | Theratechnologies Inc. | Combination therapies comprising peptide-drug conjugates targeting sortilin |
| WO2025236098A1 (en) * | 2024-05-16 | 2025-11-20 | Theratechnologies Inc. | Peptide conjugates of maytansinoids and uses thereof |
| WO2026021513A1 (zh) * | 2024-07-25 | 2026-01-29 | 上海湃鸿生物科技有限公司 | 一种多肽药物偶联物及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016270874B2 (en) * | 2015-06-03 | 2018-12-06 | Tairx, Inc. | Novel use of aryl-quinolin derivatives as inhibitors of vasculogenic mimicry |
| CA3006313C (en) * | 2015-11-24 | 2020-02-11 | Transfert Plus, S.E.C. | Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy |
-
2019
- 2019-08-26 US US17/270,787 patent/US20220000971A1/en active Pending
- 2019-08-26 CA CA3110414A patent/CA3110414A1/en active Pending
- 2019-08-26 AU AU2019324747A patent/AU2019324747A1/en active Pending
- 2019-08-26 EP EP19852741.8A patent/EP3844190A4/en active Pending
- 2019-08-26 WO PCT/CA2019/051170 patent/WO2020037434A1/en not_active Ceased
- 2019-08-26 JP JP2021534405A patent/JP7592320B2/ja active Active
- 2019-08-26 CN CN201980069301.0A patent/CN113286820B/zh active Active
-
2021
- 2021-02-23 IL IL281043A patent/IL281043A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021535209A5 (https=) | ||
| JP2019501141A5 (https=) | ||
| ES2882634T3 (es) | Compuestos peptídicos y conjugados con péptidos para el tratamiento del cáncer mediante quimioterapia mediada por receptores | |
| JP7592320B2 (ja) | ソルチリン受容体を標的化し血管擬態を阻害するための方法及び化合物 | |
| CN102762586B (zh) | 治疗肽 | |
| CN106132959B (zh) | 用于缀合的细胞毒性微管溶素化合物 | |
| JP2020515578A5 (https=) | ||
| CA3067311A1 (en) | Cd38 antibody drug conjugate | |
| CN103044521B (zh) | 天冬氨酸酶靶向激活的阿霉素衍生物、其制备方法和用途 | |
| CN112386707B (zh) | 一种肿瘤靶向多肽药物偶联物及其制备方法 | |
| CN107849090A (zh) | 抗体药物偶联物 | |
| ITMI20100093A1 (it) | Peptidi ciclici che legano il recettore cxcr4 e relativi usi in campo medico e diagnostico | |
| KR102224965B1 (ko) | 세포 투과성 펩티드 및 이를 포함하는 컨쥬게이트 | |
| RU2014134409A (ru) | Конъюгаты этопозида и доксорубицина для доставки лекарственных средств | |
| JP2020508985A5 (https=) | ||
| JP2018509394A5 (https=) | ||
| JP2012505922A5 (https=) | ||
| CN102036676A (zh) | 新颖的双重靶向性抗肿瘤轭合物 | |
| JPWO2020037434A5 (https=) | ||
| BG65926B1 (bg) | Кахалалидни съединения | |
| JP2019535702A (ja) | ジンセンチド及びジンセンチド様ペプチドの調製及び使用 | |
| KR20210125484A (ko) | 항체 약물 결합체에 사용되는 약물-링커 mc-mmaf의 제조 방법 및 이의 중간체 | |
| JP2023505509A (ja) | ポリエチレングリコール複合薬、ならびにその調製方法およびその使用 | |
| WO2018069851A2 (en) | C-met antibody drug conjugate | |
| KR20230167033A (ko) | 암 줄기 세포를 표적화하기 위한 방법 및 소르틸린 결합 접합체 화합물 |